首页 正文

Targeting MYC for the treatment of breast cancer: use of the novel MYC-GSPT1 degrader, GT19630

{{output}}
Background: Since MYC is one of the most frequently altered driver genes involved in cancer formation, it is a potential target for new anti-cancer therapies. Historically, however, MYC has proved difficult to target due to the a... ...